Ready to play
Ready to play
Reports indicate that Moderna's stock declined by 8.8%, reaching $145, meaning a loss of approximately $14 per share during today's trading. The decline is attributed to market volatility and the overall impact on major company stocks, in the context of global financial market fluctuations influenced by hopes of reopening the Hormuz Strait, falling oil prices, and expectations about the performance of U.S. stocks, including the S&P 500 index, which is targeted to reach the 7,900-point level.
Notice: This Is an AI-Generated Summary
Comments (0)